In addition, both UrC and CRC have low rates genomic loss (3% and 4–10%) but relative high rates of PTEN protein loss (20% and 40%), suggesting an epigenetic regulation for this gene in both tumor types. The gene discussed is PTEN; the disease is neoplasm.